GGT serves as an extracellular degradation enzyme of GSH, catalyzing enzymatic degradation products to enter cells and providing an additional cysteine source for intracellular GSH synthesis
The researchers further suggest that GHRPs may also increase BMC/BMD
These adverse effectsincluding nausea, vomiting, diarrhoea, constipation, and abdominal discomfortare dose-dependent and represent the most frequent reason for treatment discontinuation
reliable clinical protocols for diverse women's applications require considerably more trial data
Common liability to addiction and gateway hypothesis: theoretical, empirical and evolutionary perspective
Methodological Limitations Several limitations in the current literature should be noted: small sample sizes, often short study durations, manufacturer funding for biomimetic peptides, and the absence of direct comparisons with reference treatments